Stockscreener 앱 받기
454.22
2.76%
12.22
시간 외 거래:
454.22
Madrigal Pharmaceuticals Inc 주식(MDGL)의 최신 뉴스
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Seven new Madrigal hires get stock awards that vest over 4 years - Stock Titan
Groupama Asset Managment Sells 13,447 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal grants inducement awards to five employees - MSN
Madrigal outlines robust 2026 net sales growth and expanding pipeline amid 50% MASH market surge - MSN
Madrigal Pharmaceuticals grants equity awards to 20 new employees - MSN
Madrigal slides more than 5% as wider Q4 loss tempers strong sales growth - MSN
Madrigal inks licensing deal with China’s Suzhou Ribo for MASH drugs - MSN
2,600 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Bought by Bamco Inc. NY - MarketBeat
Iron Triangle Partners LP Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
First Light Asset Management LLC Takes Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals, Inc. $MDGL Stock Position Raised by Baker BROS. Advisors LP - MarketBeat
32,662 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Bought by Ally Bridge Group NY LLC - MarketBeat
Madrigal Pharmaceuticals, Inc. $MDGL Shares Sold by ArrowMark Colorado Holdings LLC - MarketBeat
120,000 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Purchased by Alkeon Capital Management LLC - MarketBeat
Madrigal Pharmaceuticals presence at Liver Connect Conference as attendance doubles - Traders Union
Avoro Capital Advisors LLC Cuts Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Is Rezdiffra’s Near‑US$1 Billion Debut Reshaping The Investment Case For Madrigal Pharmaceuticals (MDGL)? - simplywall.st
Connor Clark & Lunn Investment Management Ltd. Reduces Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
MDGL SEC FilingsMadrigal Pharmac 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Pullback - simplywall.st
Barclays PLC Cuts Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals to Present Breakthrough Resmetirom Data at EASL Congress 2025 - MSN
Madrigal Pharmaceuticals Grants Equity Awards to 20 New Employees - MyChesCo
Is Madrigal Pharmaceuticals (MDGL) Pricing Look Interesting After Long Term Share Price Surge? - Yahoo Finance
2 Under-the-Radar Stocks to Buy and Hold - The Globe and Mail
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy - Finviz
Fieldview Capital Management LLC Invests $2.14 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds - Insider Monkey
Discipline and Rules-Based Execution in MDGL Response - Stock Traders Daily
Rhenman & Partners Asset Management AB Purchases Shares of 18,250 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Madrigal Pharmaceuticals EVP Dier sells $854k in stock - Investing.com
Madrigal Pharmaceuticals EVP Dier sells $854k in stock By Investing.com - Investing.com South Africa
Pharma News: Why Madrigal Pharmaceuticals Inc. stock could be next big winnerTrade Volume Report & High Accuracy Swing Entry Alerts - Naître et grandir
Madrigal Pharmaceuticals (NASDAQ:MDGL) CFO Sells $853,984.34 in Stock - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells $718,316.22 in Stock - MarketBeat
Market Review: Why Madrigal Pharmaceuticals Inc. stock could be next big winnerPortfolio Update Summary & Stock Timing and Entry Methods - Naître et grandir
Madrigal Pharmaceuticals (NASDAQ:MDGL) General Counsel Sells $155,498.40 in Stock - MarketBeat
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 491 Shares of Stock - MarketBeat
Madrigal Pharmaceuticals CEO Sibold sells $718k in shares By Investing.com - Investing.com Canada
Madrigal (NASDAQ: MDGL) CFO sells stock and gets new equity grants - Stock Titan
Madrigal Pharmaceuticals general counsel sells $155k in stock By Investing.com - Investing.com Canada
Madrigal Pharmaceuticals CEO Sibold sells $718k in shares - Investing.com
[144] MADRIGAL PHARMACEUTICALS, INC. SEC Filing - Stock Titan
[Form 4] MADRIGAL PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Madrigal Pharmaceuticals (MDGL) GC gets equity grants and tax sale - Stock Titan
Madrigal (NASDAQ: MDGL) CCO logs tax sale and new equity grants - Stock Titan
Carole Huntsman to sell 419 shares — Madrigal (NASDAQ: MDGL) Form 144 - Stock Titan
Insider sales by Madrigal (MDGL) include 24,800 and 18,650-share trades - Stock Titan
Madrigal Pharmaceuticals (MDGL) reports record 2025 revenue driven by Rezdiffra success - MSN
Teachers Retirement System of The State of Kentucky Invests $1.32 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal gains after Rezdiffra patent win - MSN
Aug Shorts: Will UnitedHealth Group Incorporated stock go up in YEARQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Risk Check: Can Madrigal Pharmaceuticals Inc weather a recessionWeekly Stock Analysis & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Segall Bryant & Hamill LLC Invests $10.32 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Weakness - simplywall.st
Madrigal Pharmaceuticals: How Noninvasive Data Is Powering a Smarter Clinical Strategy! - Smartkarma
1.20%
0.06%
자본화:
|
볼륨(24시간):